Millennium Management’s Urovant Sciences Ltd. UROV Stock Holding History

Millennium Management’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-34,578	Closed	-$340K	–	5004
2020 Q2	$340K	Buy	+34,578	New	+$332K	﹤0.01%	3610
2020 Q1	–	Sell	-16,970	Closed	-$263K	–	4802
2019 Q4	$263K	Sell	16,970 -22,415	-57%	-$243K	﹤0.01%	3731
2019 Q3	$372K	Sell	39,385 -399,526	-91%	-$3.47M	﹤0.01%	3446
2019 Q2	$3.47M	Sell	438,911 -100,978	-19%	-$828K	0.01%	2064
2019 Q1	$5.43M	Buy	539,889 +136,239	+34%	+$1.4M	0.01%	1695
2018 Q4	$2.66M	Sell	403,650 -91,114	-18%	-$829K	﹤0.01%	2023
2018 Q3	$5.94M	Buy	+494,764	New	+$5.85M	0.01%	1679

Other funds holding UROV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's UROV Position: Q3 2020 in Review

Millennium Management sold out of Urovant Sciences Ltd. (UROV) in Q3 2020, closing a stake of 34,578 shares — an estimated $340K sold.

Millennium Management first reported a position in UROV in Q3 2018 and held it in 7 quarters. The position peaked at $5.94M in Q3 2018. 23 funds tracked by Wall St. Rank hold UROV as of Q3 2020.

Millennium Management reported no remaining Urovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
Millennium Management sold 34,578 Urovant Sciences Ltd. shares in Q3 2020, an estimated $340K.
Millennium Management first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 7 quarters.
Millennium Management's Urovant Sciences Ltd. position peaked at $5.94M in Q3 2018.
23 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.